Malegra FXT

Malegra FXT

Price from 52.00 $
Product dosage: 140mg
Package (num)Per pillPriceBuy
30$1.75$52.48 (0%)🛒 Add to cart
60$1.43$104.95 $85.78 (18%)🛒 Add to cart
90$1.31$157.43 $118.07 (25%)🛒 Add to cart
120$1.26$209.91 $151.38 (28%)🛒 Add to cart
180$1.20$314.86 $215.96 (31%)🛒 Add to cart
270
$1.16 Best per pill
$472.30 $312.85 (34%)🛒 Add to cart

Similar products

Malegra FXT Plus: Dual-Action Solution for Erectile Dysfunction and Premature Ejaculation

Malegra FXT Plus is a clinically-formulated combination medication designed to address two of the most prevalent male sexual health concerns: erectile dysfunction and premature ejaculation. By integrating Sildenafil Citrate and Dapoxetine into a single tablet, this product offers a comprehensive therapeutic approach, enhancing both erectile function and ejaculatory control. It is manufactured under stringent quality standards, ensuring reliability and efficacy for men seeking to improve their sexual performance and confidence. Consultation with a healthcare provider is recommended to determine suitability based on individual health profiles.

Features

  • Contains Sildenafil Citrate (100mg) and Dapoxetine (60mg) in a single tablet
  • Dual-action formula targeting both erectile dysfunction and premature ejaculation
  • Rapid onset of action, typically within 30–60 minutes
  • Extended duration of efficacy for Sildenafil (up to 4–6 hours) and Dapoxetine (up to 24 hours for ejaculatory control)
  • Film-coated for ease of swallowing and reduced aftertaste
  • Manufactured in FDA-approved facilities adhering to GMP standards

Benefits

  • Improves the ability to achieve and maintain firm erections suitable for sexual activity
  • Significantly prolongs intravaginal ejaculatory latency time, enhancing sexual endurance
  • Increases confidence and reduces anxiety related to sexual performance
  • Provides a convenient, all-in-one solution instead of multiple medications
  • Supports more satisfying and spontaneous sexual experiences for both partners
  • Backed by clinical evidence demonstrating efficacy and safety in treated populations

Common use

Malegra FXT Plus is commonly prescribed for adult men experiencing both erectile dysfunction and premature ejaculation concurrently. It is used on an as-needed basis approximately 1–3 hours before anticipated sexual activity. The medication is intended for heterosexual sexual intercourse and is not recommended for use in women, adolescents, or men without these specific diagnoses. It should be used only when prescribed by a qualified medical professional after a thorough evaluation of the patient’s cardiovascular health, psychological status, and contraindications.

Dosage and direction

The recommended dosage is one tablet taken orally with a full glass of water, 1–3 hours before sexual activity. It may be taken with or without food, though high-fat meals may delay the onset of action. Do not exceed one tablet within a 24-hour period. The tablet should be swallowed whole and not crushed, chewed, or split. Dosage adjustments may be necessary for patients with hepatic impairment, renal insufficiency, or those taking interacting medications—always follow the prescribing physician’s instructions.

Precautions

  • Not intended for use by women or individuals under 18 years of age
  • Avoid consumption of grapefruit or grapefruit juice, as it may increase drug concentrations and side effects
  • Use with caution in patients with a history of cardiovascular disease, including angina, arrhythmia, or recent myocardial infarction
  • May cause dizziness or syncope; avoid activities requiring alertness such as driving or operating machinery until effects are known
  • Not recommended for patients with severe hepatic or renal impairment without medical supervision
  • Sexual activity may pose cardiac risk; patients should be evaluated for cardiovascular fitness before use

Contraindications

  • Hypersensitivity to Sildenafil Citrate, Dapoxetine, or any excipients in the formulation
  • Concurrent use of nitrates or nitric oxide donors (e.g., nitroglycerin, isosorbide mononitrate) in any form
  • Patients with a history of non-arteritic anterior ischemic optic neuropathy (NAION)
  • Severe cardiovascular disorders, including unstable angina, heart failure, or recent stroke
  • Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) or monoamine oxidase inhibitors (MAOIs)
  • Hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption

Possible side effects

Common side effects may include headache, flushing, dizziness, nasal congestion, dyspepsia, nausea, and insomnia. Less frequently, blurred vision, palpitations, dry mouth, diarrhea, or orthostatic hypotension may occur. Rare but serious adverse effects include priapism (prolonged erection lasting more than 4 hours), syncope, severe cardiovascular events, serotonin syndrome (especially with other serotonergic drugs), and sudden hearing or vision loss. Discontinue use and seek immediate medical attention if serious side effects occur.

Drug interaction

Malegra FXT Plus has the potential for significant interactions with:

  • Nitrates and recreational drugs containing nitrites (e.g., poppers), which can cause severe hypotension
  • Alpha-blockers (e.g., doxazosin), other antihypertensives, and PDE5 inhibitors, increasing risk of hypotension
  • Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole) and inducters (e.g., rifampin), altering plasma levels
  • Serotonergic agents including SSRIs, SNRIs, tricyclic antidepressants, and triptans, increasing risk of serotonin syndrome
  • Protease inhibitors used in HIV treatment, which may elevate Dapoxetine concentrations

Missed dose

Malegra FXT Plus is not intended for regular daily dosing; it is taken on an as-needed basis. If a dose is missed and sexual activity is still anticipated, take one tablet with water as long as it is within the allowable time frame (at least 24 hours since the last dose). Do not double the dose to make up for a missed one.

Overdose

In case of suspected overdose, seek immediate medical attention or contact a poison control center. Symptoms may include severe hypotension, syncope, prolonged or painful erection, serotonin syndrome (agitation, confusion, tachycardia), or cardiovascular collapse. Supportive measures should be administered, including monitoring of vital signs and ECG. There is no specific antidote; treatment is symptomatic.

Storage

Store at room temperature (15–30°C or 59–86°F) in a dry place, protected from light and moisture. Keep the container tightly closed and out of reach of children and pets. Do not use after the expiration date printed on the packaging. Dispose of unused or expired medication properly according to local guidelines, preferably through a drug take-back program.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Malegra FXT Plus is a prescription medication and should be used only under the supervision of a qualified healthcare provider. Individual results may vary. Always read the patient information leaflet and follow your doctor’s instructions. The manufacturer is not liable for misuse or adverse outcomes resulting from unapproved use.

Reviews

“After struggling with both ED and PE for years, Malegra FXT Plus has been a game-changer. My confidence is restored, and the convenience of one pill is excellent.” — Mark T., 52
“Effective, but the initial dizziness was noticeable. My doctor adjusted the timing, and now it works well with minimal side effects.” — James L., 48
“I appreciate the balanced effect—it doesn’t just help with erections but also delays ejaculation meaningfully. Definitely recommend discussing with your doctor first.” — Robert K., 55
“Noticeable improvement in staying power and erection quality. No serious side effects, though mild headache sometimes occurs.” — David P., 50
“As a urologist, I’ve prescribed this combination for suitable patients with dual complaints. When used correctly, outcomes are generally positive with careful monitoring.” — Dr. Elena Morris, MD